Dividend Increases, Acquisitions, New Contracts, and Price Movements - Analyst Notes on LyondellBasell, Westlake, Flotek, Cabot, and Sensient Technologies

NEW YORK, March 5, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding LyondellBasell Industries NV (NYSE: LYB), Westlake Chemical Corp. (NYSE: WLK), Flotek Industries Inc. (NYSE: FTK), Cabot Corp. (NYSE: CBT), and Sensient Technologies Corporation (NYSE: SXT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

LyondellBasell Industries NV Analyst Notes

On February 20, 2014, LyondellBasell Industries NV (LyondellBasell) announced that its Board of Directors has authorized and declared an interim dividend of $0.60 per share. The interim dividend is payable on March 17, 2014, to shareholders of record on March 3, 2014, with an ex-dividend date of February 27, 2014. The full analyst notes on LyondellBasell Industries NV are available to download free of charge at:

http://www.AnalystsReview.com/03052014/LYB/report.pdf

--

Westlake Chemical Corp. Analyst Notes

On February 18, 2014, Westlake Chemical Corp. (Westlake) announced that its Board of Directors has declared a two-for-one split of the Company's common stock. The Company also announced an increase in the quarterly cash dividend on the Company's common stock to $0.252 per share, representing 12% growth on a pre-split basis. "These actions reflect the financial strength of the company," said Albert Chao, President and CEO. "The cash dividend increase, the second in less than a year, and the stock split demonstrates the Board's continued confidence in our ability to deliver strong earnings." The two-for-one common stock split will be accomplished by means of a stock dividend, to be distributed on March 18, 2014 to stockholders of record as of February 28, 2014. The cash dividend is payable on March 18, 2014 to stockholders of record as of February 28, 2014, and will be paid on the pre-split shares. The full analyst notes on Westlake Chemical Corp. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/WLK/report.pdf

--

Flotek Industries Inc. Analyst Notes

On February 11, 2014, Flotek Industries Inc. (Flotek) announced that it has entered into a Letter of Intent (LOI) to acquire Plano, Texas based SiteLark, LLC (SiteLark). Flotek will provide total initial consideration of $0.6 million in cash and Flotek common stock for SiteLark, subject to completion of due diligence and certain adjustments. "The addition of Dee and the SiteLark team to the Flotek family is another key step in our quest to build a best-in-class EOR practice focused on offering key services from initial modeling of projects to evaluation and adjustment of those projects," said John Chisholm, Chairman, President and CEO of Flotek. Upon the completion of due diligence and other requirements, Flotek expects to close on the SiteLark acquisition by March 31, 2014. The full analyst notes on Flotek Industries Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/FTK/report.pdf

--

Cabot Corp. Analyst Notes

On February 24, 2014, Cabot Corp. (Cabot) announced that it has entered into a contract to provide its DARCO® Hg family of activated carbon products to a Northern US power generator. The contract is valued at up to $6 million and will allow the utility to meet stringent federal regulations for mercury emissions in the US. Under the terms of the contract, Cabot will supply DARCO Hg-LH and DARCO Hg-LH Extra powdered activated carbon to satisfy 100% of the utility's requirements across its four boilers at three generating stations. Bart Kalkstein, Vice President and General Manager, Global Emission Control Technologies, Cabot Purification Solutions, said, "We are continuing to win contracts like this as mercury-emitting utilities look to use activated carbon to meet these requirements and seek an experienced and technically advanced partner as their supplier. Moreover, our robust supply chain and secure source of supply will ensure that we can fulfill our customers' needs as market demand increases - distinguishing us from the competition." The full analyst notes on Cabot Corp. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/CBT/report.pdf

--

Sensient Technologies Corporation Analyst Notes

On March 3, 2014, Sensient Technologies Corp.'s (Sensient) stock rose 0.59% to end the day at $52.74, compared to the previous day's closing price at $52.43. The Company's stock increased 0.25% over the past three trading days, compared to the Dow Jones Industrial Average which went down 0.19% during the same trading period. The full analyst notes on Sensient Technologies Corp. are available to download free of charge at:  

http://www.AnalystsReview.com/03052014/SXT/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED